HMGCR and cardiovascular disorder: Simvastatin is a lipid-lowering agent clinically applied in cardiovascular disease, which blocks the transformation of HMG-CoA to mevalonate by competitively suppressing HMG-CoA reductase and reducing cholesterol synthesis [58].